| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |